Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masahiro Ohara
Observed name:
MASAHIRO OHARA
Institutions:
Saitama International Medical Center,
Saitama Medical University
Observed institutions:
Saitama International Medical Center,
Saitama Medical University
ORCID:
0000-0003-4174-5052
Observed ORCID:
0000-0003-4174-5052
OpenAlex ID:
A5123888458
Association between tumor-infiltrating lymphocytes and oncotype DX estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 single gene scores in hormone receptor-positive/HER2-negative breast cancer
2026
·
Masahiro Ohara
, Emi Mikami
, et al.
·
Frontiers in Oncology
·
2
PDF
Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment
2026
·
AKIHIRO FUJIMOTO
, YUKI ICHINOSE
, et al.
·
Cancer Diagnosis & Prognosis
·
1
PDF
Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune‑related colitis: A case report
2026
·
Wakako Inohana
, Masahiro Ohara
, et al.
·
Molecular and Clinical Oncology
·
1
PDF
Baseline peripheral blood immune markers associated with clinical outcomes in patients with advanced breast cancer treated with trastuzumab deruxtecan
2026
·
Akihiro Fujimoto
, Yuki Ichinose
, et al.
·
BMC Cancer
A case of recurrent breast cancer with severe hepatic dysfunction: Integrating narrative-based medicine and clinical decision-making
2026
·
Kei Yamaguchi
, Masahiro Ohara
, et al.
·
Palliative & Supportive Care
PDF
Septic Pulmonary Embolism due to Methicillin-Resistant Staphylococcus aureus Bacteremia during Adjuvant Chemotherapy for Breast Cancer: A Case Report
2026
·
Aya Asano
, Masafumi Seki
, et al.
·
Case Reports in Oncology
PDF
Show more works
View as search
Works count:
6
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type